Ippokratis Korantzis

St Luke's Hospital
Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia.

Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia.

Journal: The New England journal of medicine

Published: March 11, 2026

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort.

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 13, 2025

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 13, 2025

Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece-The TRINITY Study.

Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece-The TRINITY Study.

Journal: Cancers

Published: October 24, 2025

Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY study.

Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY study.

Journal: BMC cancer

Published: June 13, 2025

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.

Journal: The New England journal of medicine

Published: June 02, 2025

Plain language summary: tarlatamab for patients with previously treated small cell lung cancer.

Plain language summary: tarlatamab for patients with previously treated small cell lung cancer.

Journal: Future oncology (London, England)

Published: November 12, 2024

Real-world management strategies and clinical outcomes of metastatic HER2-positive breast cancer in Greece in the second-line setting and beyond (the togetHER study).

Real-world management strategies and clinical outcomes of metastatic HER2-positive breast cancer in Greece in the second-line setting and beyond (the togetHER study).

Journal: BMC cancer

Published: January 24, 2024

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.

Journal: The New England journal of medicine

Published: October 20, 2023

Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.

Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.

Journal: Anticancer research

Published: January 28, 2023

Genetic Predisposition to Male Breast Cancer: A Case Series.

Genetic Predisposition to Male Breast Cancer: A Case Series.

Journal: Anticancer research

Published: October 11, 2022

Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.

Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.

Journal: JTO clinical and research reports

Published: August 07, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026